Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API     

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


       2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

happy family

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  
     
 
   PRODUCT LIST
   Home
   API
   Pharmaceuticals API List
   Chemicals >>>
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 
   

stronger activity


 

 

 

 

 

 

 

 

 

 

 

 

 

 

























 

 

 

HOME >> Chemicals >> Chemicals List 1 >> Phenylpropanolamine

Phenylpropanolamine

CAS number 14838-15-4
Phenylpropanolamine  powder
Phenylpropanolamine Formula C9H13NO                              

Identifiers


Systematic (IUPAC) name (1R,2S)-2-amino-1-phenyl-propan-1-ol

Identifiers

CAS number 14838-15-4
ATC code R01BA01
PubChem 26934
DrugBank APRD00457
ChemSpider 25082

Chemical data

Formula C9H13NO
Mol. mass 151.206 g/mol
Pharmacokinetic data
Half life 2.1 to 3.4 hours.
Therapeutic considerations
Routes Oral

Phenylpropanolamineis a drug ingredient of the phenethylamine family used as a decongestantin prescription and nonprescription (over the counter) cough and cold, and sinus remedies, and some combination allergy medications. It is also present in an appetite suppressant.

Phenylpropanolamine (PPA) is used to treat nasal congestion associated with the common cold, allergies, hay fever, or other respiratory illnesses (e.g., rhinitis, sinusitis). It has also been used as a nonprescription diet-aid for weight loss.

The Food and Drug Administration (FDA) is taking steps to remove phenylpropanolamine (PPA) from all drug products and has requested that all drug companies discontinue marketing products containing PPA. In addition, FDA has issued a public health advisory concerning phenylpropanolamine.

This drug is an ingredient that was used in many over-the-counter (OTC) and prescription cough and cold medications as a decongestant and in OTC weight loss products.

In response to the request made by FDA in November 2000, many companies have voluntarily reformulated and are continuing to reformulate their products to exclude PPA while FDA proceeds with the regulatory process necessary to remove PPA from the market.

Use caution when driving, operating machinery, or performing other hazardous activities. Phenylpropanolamine may cause dizziness or drowsiness. If you experience dizziness or drowsiness, avoid these activities. Never take this medication in larger doses or more often than is recommended. Too much phenylpropanolamine could be very harmful.

Before taking this medication, tell your doctor if you have

* high blood pressure;
* any type of heart disease, hardening of the arteries, or irregular heartbeat;
* thyroid problems;
* diabetes;
* glaucoma or increased pressure in your eye;
* an enlarged prostate or difficulty urinating; or
* liver or kidney disease.

Use caution when driving, operating machinery, or performing other hazardous activities. Phenylpropanolamine may cause dizziness or drowsiness.

If you experience dizziness or drowsiness, avoid these activities. Never take this medication in larger doses or more often than is recommended. Too much phenylpropanolamine could be very harmful.

 

Note /Government Notification: These chemicals are designated as those that are used in the manufacture of the controlled substances and are important to the manufacture of the substances. For any (Control Substance) products Import and Export *** subjected to your country government laws /control substance ACT.
Information: The information on this web page is provided to help you to work safely, but it is intended to be an overview of hazards, not a replacement for a full Material Safety Data Sheet (MSDS). MSDS forms can be downloaded from the web sites of many chemical suppliers. ,also that the information on the PTCL Safety web site, where this page was hosted, has been copied onto many other sites, often without permission. If you have any doubts about the veracity of the information that you are viewing, or have any queries, please check the URL that your web browser displays for this page. If the URL begins "www.tajapi.com/www/Denatonium Benzoate.htm/" the page is maintained by the Safety Officer in Physical Chemistry at Oxford University. If not, this page is a copy made by some other person and we have no responsibility for it.
The Controlled Substances Act (CSA) was enacted into law by the Congress of the United States as Title II of the Comprehensive Drug Abuse Prevention and Control Act of 1970.[1] The CSA is the federal U.S. drug policy under which the manufacture, importation, possession, use and distribution of certain substances is regulated. The Act also served as the national implementing legislation for the Single Convention on Narcotic Drugs

Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

  Taj pharmaceuticals API Logo

Phenylpropanolamine

Chemical Manufacturer In India

Anthranilic acid

Denatonium Benzoate

Ephedrine

Ergonovine

Ergotamine

Hydroiodic acid

Norpseudoephedrine

Phenylpropanolamine

Phosphorus

Benzaldehyde

Nitroethane

Gamma butyrolactone

N-Phenethyl-4-piperidinone

Methylamine

Ethylamine

Isosafrole

Safrole

Piperonal

N-methylephedrine

N-methylpseudoephedrine

Copyright Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap

 

taj group logo
2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals  Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals  Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.